[Articles] Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Di |2025-03-06T00:30:01+01:00Marzo 6th, 2025|Categorie: Coronavirus Lancet|

Vaccination with H56:IC31 at treatment completion for pulmonary tuberculosis did not reduce the risk of recurrent disease. H56:IC31 was well tolerated and immunogenic but might have increased the risk of relapses by endogenous strains.

[Articles] Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Di |2025-03-06T00:30:01+01:00Marzo 6th, 2025|Categorie: Coronavirus Lancet|

Vaccination with H56:IC31 at treatment completion for pulmonary tuberculosis did not reduce the risk of recurrent disease. H56:IC31 was well tolerated and immunogenic but might have increased the risk of relapses by endogenous strains.

[Articles] Immunogenicity, safety, and efficacy of the vaccine H56:IC31 in reducing the rate of tuberculosis disease recurrence in HIV-negative adults successfully treated for drug-susceptible pulmonary tuberculosis: a double-blind, randomised, placebo-controlled, phase 2b trial

Di |2025-03-06T00:30:01+01:00Marzo 6th, 2025|Categorie: Coronavirus Lancet|

Vaccination with H56:IC31 at treatment completion for pulmonary tuberculosis did not reduce the risk of recurrent disease. H56:IC31 was well tolerated and immunogenic but might have increased the risk of relapses by endogenous strains.

[Correspondence] Beyond acute watery diarrhoea: new cholera surveillance guidance

Di |2025-02-27T00:34:34+01:00Febbraio 27th, 2025|Categorie: Coronavirus Lancet|

Despite considerable efforts to end cholera as a global public health threat, the past few years have seen an upsurge in cholera outbreaks worldwide.1 Cholera surveillance has limited specificity by primarily counting acute watery diarrhoea with restri...

Torna in cima